118 related articles for article (PubMed ID: 7542406)
1. Interindividual variability in the urinary excretion of inorganic arsenic metabolites by C57 BL/6J mice: possible involvement of a thiol/disulfide exchange mechanism.
Morel G; Cluet JL; Telolahy P; Yang HM; Thieffry N; de Ceaurriz J
Toxicol Lett; 1995 Jul; 78(2):111-7. PubMed ID: 7542406
[TBL] [Abstract][Full Text] [Related]
2. An attempt to explain interindividual variability in 24-h urinary excretion of inorganic arsenic metabolites by C57 BL/6J mice.
Telolahy P; Morel G; Cluet JL; Yang HM; Thieffry N; de Ceaurriz J
Toxicology; 1995 Nov; 103(2):105-12. PubMed ID: 8545842
[TBL] [Abstract][Full Text] [Related]
3. Study of factors influencing the in vivo methylation of inorganic arsenic in rats.
Buchet JP; Lauwerys R
Toxicol Appl Pharmacol; 1987 Oct; 91(1):65-74. PubMed ID: 3672518
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man.
Buchet JP; Lauwerys R; Roels H
Int Arch Occup Environ Health; 1981; 48(1):71-9. PubMed ID: 6894292
[TBL] [Abstract][Full Text] [Related]
5. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic.
Foà V; Colombi A; Maroni M; Buratti M; Calzaferri G
Sci Total Environ; 1984 Mar; 34(3):241-59. PubMed ID: 6719100
[TBL] [Abstract][Full Text] [Related]
6. The influence of liver disease on the methylation of arsenite in humans.
Buchet JP; Geubel A; Pauwels S; Mahieu P; Lauwerys R
Arch Toxicol; 1984 Sep; 55(3):151-4. PubMed ID: 6497648
[TBL] [Abstract][Full Text] [Related]
7. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig.
Healy SM; Zakharyan RA; Aposhian HV
Mutat Res; 1997 Jun; 386(3):229-39. PubMed ID: 9219561
[TBL] [Abstract][Full Text] [Related]
9. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
Csanaky I; Gregus Z
Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
[TBL] [Abstract][Full Text] [Related]
11. Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile.
Kobayashi Y; Hirano S
Toxicol Appl Pharmacol; 2008 Oct; 232(1):33-40. PubMed ID: 18619986
[TBL] [Abstract][Full Text] [Related]
12. Speciation of arsenic metabolites in the urine of occupational workers and experimental rats using an optimised hydride cold-trapping method.
Ng JC; Johnson D; Imray P; Chiswell B; Moore MR
Analyst; 1998 May; 123(5):929-33. PubMed ID: 9709483
[TBL] [Abstract][Full Text] [Related]
13. Methylation study of a population environmentally exposed to arsenic in drinking water.
Hopenhayn-Rich C; Biggs ML; Smith AH; Kalman DA; Moore LE
Environ Health Perspect; 1996 Jun; 104(6):620-8. PubMed ID: 8793350
[TBL] [Abstract][Full Text] [Related]
14. Interaction of plasma glutathione redox and folate deficiency on arsenic methylation capacity in Bangladeshi adults.
Niedzwiecki MM; Hall MN; Liu X; Slavkovich V; Ilievski V; Levy D; Alam S; Siddique AB; Parvez F; Graziano JH; Gamble MV
Free Radic Biol Med; 2014 Aug; 73():67-74. PubMed ID: 24726863
[TBL] [Abstract][Full Text] [Related]
15. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.
Hsueh YM; Huang YL; Huang CC; Wu WL; Chen HM; Yang MH; Lue LC; Chen CJ
J Toxicol Environ Health A; 1998 Jul; 54(6):431-44. PubMed ID: 9661909
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats.
Yoshida K; Inoue Y; Kuroda K; Chen H; Wanibuchi H; Fukushima S; Endo G
J Toxicol Environ Health A; 1998 Jun; 54(3):179-92. PubMed ID: 9643871
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.
Kenyon EM; Del Razo LM; Hughes MF
Toxicol Sci; 2005 May; 85(1):468-75. PubMed ID: 15703264
[TBL] [Abstract][Full Text] [Related]
18. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
Hayakawa T; Kobayashi Y; Cui X; Hirano S
Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
[TBL] [Abstract][Full Text] [Related]
19. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
20. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh.
Gamble MV; Liu X; Ahsan H; Pilsner R; Ilievski V; Slavkovich V; Parvez F; Levy D; Factor-Litvak P; Graziano JH
Environ Health Perspect; 2005 Dec; 113(12):1683-8. PubMed ID: 16330347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
